Recently, it has been investigated the role of a metabolic regulator that prevents obesity, fibroblast growth factor 21 (FGF21), in KRAS oncogenic context of pancreatic cancer. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.